Parecer de pré-exame
#6.23
02/03/2026
RPI 2874
Application data
Number
112021017198Type
Filing
Publication
PCT
IB2020052484 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 02/03/2026. We update with every new RPI gazette, published weekly.
Applicants
UROVANT SCIENCES GMBH
CH
Inventors
P. J. (pessoa física)
US
IPC Classification
Priority claims
US
62/820,230 · 03/18/2019
US
62/830,302 · 04/05/2019
US
62/842,435 · 05/02/2019
US
62/885,767 · 08/12/2019
US
62/897,019 · 09/06/2019
US
62/904,429 · 09/23/2019
Abstract
USO DE VIBEGRON PARA TRATAR BEXIGA HIPERATIVAA presente revelação é dirigida a um método para tratar bexiga hiperativa compreendendo administrar oralmente a um indivíduo em necessidade do mesmo uma quantidade de 75 mg de vibegron por dia.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
02/03/2026
RPI 2874
#1.3
11/16/2021
RPI 2654
#1.1
09/08/2021
RPI 2644
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.